HOME >> MEDICINE >> NEWS
Study of leukemia survivors gives hints for better care

Results from the longest follow-up study ever done of childhood acute lymphoblastic leukemia (ALL) survivors show the importance of long-term monitoring of former patients to identify complications they are at risk for developing later in life and to modify current treatments to reduce those risks, according to investigators at St. Jude Children's Research Hospital. ALL is the most common cancer in children and adolescentswith about 3,000 new cases diagnosed yearly in the United States.

The St. Jude study showed that adults who had received treatment for ALL during childhood are at increased risk for developing a secondary neoplasm during the next 30 years. Secondary neoplasms are new tumors that develop after successful treatment of an initial cancer.

A report on this work appears in the March 21 issue of the "Journal of the American Medical Association" ("JAMA").

The finding is important because the cure rate of children treated for ALL has increased dramatically since the 1960s, approaching 90 percent today at St. Jude. Therefore, it is important to monitor survivors during their entire lives to identify the long-term complications they might experience even decades after the end of their treatment, the researchers said.

Previous studies found a relatively low incidence of secondary neoplasm during the first 10 to 15 years after treatment for ALL. Those studies suggested that the incidence of these new tumors might not be significant 20 years after therapy. "On the contrary, our longer study shows that after 20 years the incidence continues to increase," said Nobuko Hijiya, M.D., assistant member in the St. Jude Oncology department. Hijiya is the first and corresponding author of the "JAMA" article.

The St. Jude study found that most of these late-onset secondary neoplasms are low-grade, or slow-growing, tumors that are curablespecifically, meningiomas (tumors arising from the membranes covering the brain) a
'"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-495-3061
St. Jude Children's Research Hospital
20-Mar-2007


Page: 1 2 3

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Study outlines how stroke, head injury can increase risk of Alzheimers disease
10. Study identifies new regulator of fat metabolism
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Study leukemia survivors gives hints for better care

(Date:5/20/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) -- ... are twice as likely to become obese adults as ... young, a new 30-year study shows. Researchers found ... higher body-mass index (BMI) and obesity, even if they ... no difference; well-off or poor, they tended toward ...
(Date:5/20/2013)... 2013 In celebration of National Women’s ... accomplishments achieved at The Feinstein Institute for Medical ... Advancing Women in Science and Medicine (AWSM) , ... Scientists, educators, business and community leaders from the ... of women in science. , “Women face unique ...
(Date:5/20/2013)... ANN ARBOR, Mich. As high schoolers prepare for ... a "study drug" -- a prescription stimulant or amphetamine ... University of Michigan poll shows only one in 100 ... teen has used a study drug., Study drugs refer ... attention deficit hyperactivity disorder (ADHD); commonly prescribed medicines in ...
(Date:5/20/2013)... Join Seva Foundation in celebrating its 35th Anniversary with ... Fine Arts Theater in San Francisco, featuring: Snatam ... with host Wavy Gravy. All proceeds will benefit Seva Foundation’s ... seats are $40 & $55, VIP tickets are $150 and ... row seat at the show. Tickets are available through ...
(Date:5/20/2013)... A new Benefits of Pharmacy Home Delivery ... of the MedEx Pack announced. The new ... Delivery, in order to provide useful details for those who ... Clyde Furuta, MedEx Direct owner and pharmacist said, “One of ... a product like the MedEx Pack, patients can receive their ...
Breaking Medicine News(10 mins):Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 2Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 3Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2Health News:Memorial Day Kirtan Concert Palace of Fine Arts Theater in San Francisco Featuring: Snatam Kaur, Jai Uttal, C.C. White & Shimshai with host Wavy Gravy,May 27th 7:00 PM 2Health News:Benefits of Pharmacy Home Delivery Report Published by MedEx Direct 2
(Date:5/20/2013)... 2013  Neuralstem, Inc. (NYSE MKT: CUR) today reported ... principal investigator, presented updated Phase I data from its ... the treatment of amyotrophic lateral sclerosis (ALS or ... diabetes special medical symposium in Bucharest, Romania ... Therapeutic Advances in Stem Cell Therapy," Dr. Feldman outlined ...
(Date:5/20/2013)... Mass. , May 20, 2013 ... and advisory firms for pharmaceutical and healthcare issues, ... that therapies offering a greater effect on quality ... unmet need. Given the high level of subjectivity ... of life, interviewed thought leaders state that it ...
(Date:5/19/2013)... Calif. , May 20, 2013  Whole-cell pertussis ... acellular pertussis vaccines during a large recent outbreak, according ... Whole-cell pertussis vaccines, also called DTwP, were ... with safety concerns that ultimately led to the development ... By the late 1990s, the United States ...
Breaking Medicine Technology:Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4
Cached News: